Gold bars to be exempt from tariffs, White House clarifies
Investing.com - BofA Securities raised its price target on Trupanion, Inc. (NASDAQ:TRUP) to $67.00 from $56.00 on Friday, while maintaining a Buy rating following the pet insurer’s second-quarter results. According to InvestingPro data, the stock currently trades at $48.75, with analyst targets ranging from $45 to $67, suggesting potential upside in line with BofA’s view.
The pet health insurer reported positive earnings per share in the second quarter of 2025, beating BofA’s forecast of $0.11 and consensus expectations of a $0.02 loss per share.
BofA noted that Trupanion’s earnings beat was primarily driven by a one-time realized gain of $7.8 million on preferred stock in Baystride, which came from an exchange of preferred interests for intellectual property related to the company’s food initiative.
Trupanion posted revenue of $354 million for the quarter, modestly exceeding management’s guidance range of $344-$350 million, though falling short of BofA’s forecast of $361 million.
The company’s medical loss ratio came in at 71.1%, which included 60 basis points of favorable prior-year development, while its subscription business pet count grew 4% year-over-year, essentially in line with BofA’s expectations.
In other recent news, Trupanion Inc . reported its second-quarter 2025 earnings, surpassing both earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.22, significantly above the expected -$0.04, marking a 650% surprise. Revenue reached $353.6 million, exceeding the forecast of $346.74 million by 1.97%. These results highlight the company’s strong financial performance for the quarter.
Additionally, there have been no recent reports of mergers or acquisitions involving Trupanion. Analyst firms have not reported any upgrades or downgrades for Trupanion recently. There are also no other major company developments reported at this time. These updates provide investors with the latest financial highlights and analyst insights on Trupanion.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.